Connect your AI

Boston Scientific BSX Share Repurchase Program, Authorized, Amount

Share Repurchase Program, Authorized, Amount at other companies

STERISSTE

——

Other financials

Income statement

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

Cash & equivalents$850.0M+146%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.4%

Free cash flow$171.0M-51.7%

Valuation

Market cap$67.32B-37.5%

P/E18.9×-34.3×

P/S3.3×-2.9×

Profitability

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

Returns & leverage

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's share repurchase program, authorized, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Boston Scientific's share repurchase program, authorized, amount?: Boston Scientific (BSX) reported share repurchase program, authorized, amount of $4B in Q1 2026.